Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed May 26, 2022

Accession no.
0001209191-22-032025
Filed
May 26, 2022, 8:16 AM ET
Trade date
May 25, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $148.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 25, 2022Common StockPPurchaseAcquired+12,852$2.96+$37,977.66195,969,546Indirect
May 25, 2022Common StockPPurchaseAcquired+6,000$2.96+$17,760195,975,546Indirect
May 25, 2022Common StockPPurchaseAcquired+15,190$2.98+$45,190.25195,990,736Indirect
May 25, 2022Common StockPPurchaseAcquired+800$2.98+$2,384195,991,536Indirect
May 25, 2022Common StockPPurchaseAcquired+4,782$3.00+$14,322.09195,996,318Indirect
May 25, 2022Common StockPPurchaseAcquired+10,376$3.01+$31,231.76196,006,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)